Navigation Links
Neogen launches rapid tests for ractopamine
Date:3/21/2013

LANSING, Mich., March 21, 2013 /PRNewswire/ -- As international debate continues on the use of the feed additive ractopamine, Neogen Corporation (NASDAQ: NEOG) has launched easy 10 minute tests to detect ractopamine in animal and animal feed samples.

Ractopamine is a beta-agonist drug added to feed to promote lean muscle in animals raised for meat. While many countries allow the use of ractopamine within specified limits, including the United States, regulatory agencies in other countries have banned residues of the drug, including those in the European Union, Russia, and China.

"China recently followed Russia by imposing import restrictions on certain U.S. meat products, which require documentation that the products are free of ractopamine," said Ed Bradley , Neogen's vice president of Food Safety. "While top trade officials in the U.S. view the new restrictions as unnecessary trade barriers, markets in which ractopamine residues are banned are worth hundreds of millions of dollars annually to U.S. meat producers. Until these trade issues can be resolved, companies seeking access to these markets may have no choice but to comply with the new regulations." 

To ensure compliance with the new regulations, animal samples can be easily screened for the presence of ractopamine. In addition, feed manufacturers can use simple screening tests to verify the effectiveness of their cleanup procedures when switching production from ractopamine-medicated feed to feed intended to be ractopamine-free.  

Neogen's Ractopamine Lateral Flow Device (LFD) tests are intended to screen cattle and swine samples, and swine and turkey feed samples for the presence of ractopa
'/>"/>

SOURCE Neogen Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Neogen Corporation Announces 3rd Quarter Results Conference Call
2. Neogen reports 30% increase in quarterly net income
3. Neogen Corporation Announces 1st Quarter Results Conference Call
4. Neogen reports year end results
5. Neogen Corporation Announces Year-End Results Conference Call
6. Neogen acquires Igenity from Merial
7. Neogen launches the fastest molecular pathogen test
8. Neogen Launches Fully Quantitative Lateral Flow Test for DON
9. Neogen Reports Second Quarter Results
10. Neogen Corporation Announces 2nd Quarter Results Conference Call
11. Elsevier Launches PracticeUpdate, a Free Information Portal for Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Rhythm, a biopharmaceutical company developing ... that result in metabolic disorders, announced today that it ... the U.S. Securities and Exchange Commission (SEC) relating to ... common stock. The number of shares to be offered ... yet been determined. Citigroup and Cowen and ...
(Date:8/27/2014)...   MSC , a healthcare performance improvement company ... appointment of Mary Beth Loesch to President ... experience preparing companies for rapid growth and market expansion, ... of Corporate Development and Healthcare. In that role, she ... well as corporate strategy and marketing. Previously, Loesch served ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com announces ... in its catalogue: Global Chelating Agents ... About Chelating Agent A chelating agent ... bonds with metal ions, thereby forming a metal-ion ... metal-ions have on chemical processes, formulations, and the ...
(Date:8/27/2014)... MADISON, N.J. , Aug. 27, 2014 /PRNewswire/ ... significant potential to help physicians better identify early-stage ... progression and disability, according to a new study ... from Quest Diagnostics (NYSE: DGX ) ... of the 14-3-3eta protein outperformed conventional antibody-serum testing, ...
Breaking Biology Technology:Rhythm Files Registration Statement for Proposed Initial Public Offering 2MSC names Mary Beth Loesch President and CEO 2Global Chelating Agents Market 2014-2018 2Global Chelating Agents Market 2014-2018 3Global Chelating Agents Market 2014-2018 4Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4
... COUNTY, Calif., April 28 Beckman Coulter, Inc. (NYSE: ... manufacturer and marketer of products that simplify, automate and ... March 31, 2009 results. For the first quarter, ... in constant currency terms. On a constant currency ...
... SHPGY ), the global specialty biopharmaceutical company, announces that at its,Annual General Meeting today, all resolutions contained in the ... ... Against Withheld**, 1. To receive the, ... together with the, director,s and, ...
... CITY, April 28 /PRNewswire-FirstCall/ - Medicago Inc. (TSX-V: ... effective and affordable vaccines based on proprietary manufacturing ... it has received a genetic sequence of the ... recently been identified in USA and Mexico, and ...
Cached Biology Technology:Beckman Coulter Announces First Quarter 2009 Results 2Beckman Coulter Announces First Quarter 2009 Results 3Beckman Coulter Announces First Quarter 2009 Results 4Beckman Coulter Announces First Quarter 2009 Results 5Beckman Coulter Announces First Quarter 2009 Results 6Beckman Coulter Announces First Quarter 2009 Results 7Beckman Coulter Announces First Quarter 2009 Results 8Beckman Coulter Announces First Quarter 2009 Results 9Beckman Coulter Announces First Quarter 2009 Results 10Beckman Coulter Announces First Quarter 2009 Results 11Beckman Coulter Announces First Quarter 2009 Results 12Beckman Coulter Announces First Quarter 2009 Results 13Beckman Coulter Announces First Quarter 2009 Results 14Beckman Coulter Announces First Quarter 2009 Results 15Beckman Coulter Announces First Quarter 2009 Results 16Beckman Coulter Announces First Quarter 2009 Results 17Beckman Coulter Announces First Quarter 2009 Results 18Beckman Coulter Announces First Quarter 2009 Results 19Beckman Coulter Announces First Quarter 2009 Results 20Beckman Coulter Announces First Quarter 2009 Results 21Beckman Coulter Announces First Quarter 2009 Results 22Beckman Coulter Announces First Quarter 2009 Results 23Beckman Coulter Announces First Quarter 2009 Results 24Beckman Coulter Announces First Quarter 2009 Results 25Beckman Coulter Announces First Quarter 2009 Results 26Beckman Coulter Announces First Quarter 2009 Results 27Beckman Coulter Announces First Quarter 2009 Results 28Beckman Coulter Announces First Quarter 2009 Results 29Shire plc: Results of the Annual General Meeting Held on April 28, 2009 2Medicago initiates work on Swine Flu strain 2
(Date:8/27/2014)... DURHAM, N.C. -- When we want to listen carefully ... talking. The second thing we do is stop moving ... unwanted sounds generated by our own movements. , This ... deep in the brain. Indeed, indirect evidence has long ... somehow influences the auditory cortex, which gives rise to ...
(Date:8/27/2014)... release is available in German . ... is the most common inherited disease affecting the peripheral ... the Max Planck Institute of Experimental Medicine and University ... Schwann cells is impaired in rats with the disease. ... layer known as myelin, which facilitates the rapid transfer ...
(Date:8/27/2014)... fishing traps are lost or abandoned each year in ... traps, which continue to catch fish, crabs, and other ... to habitat, fisheries, and the watermen who depend on ... newly published NOAA study. , The report, published in ... of its kind to examine the derelict fish trap ...
Breaking Biology News(10 mins):Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3Potential therapy for incurable Charcot-Marie-Tooth disease 2NOAA's Marine Debris Program reports on the national issue of derelict fishing traps 2
... DC Fascinating scientific advances across the spectrum ... be featured and explained through engaging table-top exhibits ... 15th Annual Exhibition & Reception. The exhibition/reception will ... March 24, in Rooms B338-340 of the Rayburn ...
... Alzheimer,s disease drugs currently studied in clinical trials appears ... animals, researchers at Georgetown University Medical Center report in ... . They say the results suggest that this ... drug has been able to do-- prevent the long-term ...
... Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have shown ... some blood disorders may be inherited. Their research, published ... common genetic sequence abnormality that enhances the likelihood of ... blood diseases. The investigators carried out a genome-wide ...
Cached Biology News:Science returns to the Capitol Hill spotlight at March 24 exhibition 2Science returns to the Capitol Hill spotlight at March 24 exhibition 3Science returns to the Capitol Hill spotlight at March 24 exhibition 4Alzheimer's disease therapeutic prevents long-term damage from TBI in pre-clinical studies 2Alzheimer's disease therapeutic prevents long-term damage from TBI in pre-clinical studies 3
Protein 3D structure prediction, via threading. Easy to use....
L1 Protein of Human Papilloma Virus Purified Anti-Viral-transformed cells clone CAMVIR-1, Isotype Mouse IgG 2a , 0.1 mg Consult technical datasheet for details....
ANTI 5-HYDROXYTRYPTOPHAN CONJ....
PAb to Hu-IFN-Alpha/Beta R2 [(IFNAR2) CD118], Rabbit Serum, neutralizing Binds to but does not neutralize human interferon alpha/beta receptor...
Biology Products: